scholarly article | Q13442814 |
editorial | Q871232 |
P50 | author | Nae-Yun Heo | Q88432246 |
P2093 | author name string | Nae-Yun Heo | |
P2860 | cites work | LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION | Q58236604 |
The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B | Q84544446 | ||
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 | ||
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. | Q30391932 | ||
Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B. | Q33872988 | ||
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. | Q34500537 | ||
AASLD guidelines for treatment of chronic hepatitis B. | Q34501660 | ||
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy. | Q34785683 | ||
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy | Q35597901 | ||
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. | Q37384895 | ||
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. | Q40245246 | ||
Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine. | Q42234528 | ||
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. | Q42541246 | ||
Long-term safety of lamivudine treatment in patients with chronic hepatitis B. | Q44729211 | ||
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. | Q46217486 | ||
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. | Q46575199 | ||
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. | Q46981468 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | L-alanine | Q218642 |
chronic hepatitis B | Q55779876 | ||
P304 | page(s) | 125-127 | |
P577 | publication date | 2017-06-23 | |
P1433 | published in | Clinical and molecular hepatology | Q26853927 |
P1476 | title | Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign? | |
P478 | volume | 23 |